Physician profile
Nancy A Thomas
NPI 1457599367
$1,212.89
in general payments reported to CMS, 2019-2025
20 companies · $35.94 in 2025
The $35.94 reported for 2025 was less than what a typical Adult Health (Nurse Practitioner) provider received nationally (typical 2025 total: $182).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $506 · 2022: $587 · 2023: $35.38 · 2024: $48.33 · 2025: $35.94.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $120.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $119.65 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $210.11 | 2021-2022 | |
| Novo Nordisk INC | $115.30 | 2022-2025 | Wegovy |
| Sanofi-Aventis U.S. LLC | $100.52 | 2021-2022 | |
| Lilly USA, LLC | $94.26 | 2021-2025 | Zepbound, Mounjaro |
| Janssen Pharmaceuticals, INC | $82.11 | 2021-2022 | |
| Amgen INC. | $79.70 | 2021-2022 | |
| Amarin Pharma, INC. | $75.49 | 2021-2022 | |
| Merck Sharp & Dohme LLC | $75.22 | 2021-2022 | |
| Abbott Laboratories | $64.44 | 2021-2022 | |
| Sunovion Pharmaceuticals INC. | $50.37 | 2021-2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $49.02 | 2021-2022 | |
| Pfizer INC. | $47.69 | 2021-2022 | |
| Eisai INC. | $42.93 | 2021 | |
| Daiichi Sankyo INC. | $25.63 | 2024 | Enhertu |
| Novartis Pharmaceuticals Corporation | $24.95 | 2021-2022 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $17.20 | 2022 | |
| E.R. Squibb & Sons, L.L.C. | $17.00 | 2022 | |
| Sumitomo Pharma America, INC. | $14.70 | 2023 | Gemtesa |
| Urovant Sciences INC | $13.98 | 2022 | |
| Astellas Pharma US INC | $12.27 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nancy Thomas listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.